Fundraising FoxMing capital
Venture capitalShenzhen · Seed–Series C · 6 people tracked
Find your way into Ming capital
Sign up to see every warm intro you have to Ming capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ming capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Ming Capital is a global healthcare-focused venture capital firm dedicated to improving human health by backing medical breakthroughs worldwide, with particular emphasis on innovative medicine, medical devices, and in-vitro diagnostics (IVD). It aims to combine global resources across medical innovation, entrepreneurship, management, commercial markets, and capital markets using onshore-offshore parallel funds and parallel investments. Its strategic goals are to support entrepreneurs, prosper investors, reward partners, and enhance health, guided by values of collective wisdom and integrity for value creation.
Source: firm website, verified Oct 25, 2026.
Team · 6 people
from the firm's website & public directoriesFounding Partner with over 25 years of experience in VC/PE investment and M&A investment banking, having worked with New Hope Industry Funds, Rothschild Investment Banking, and China Leasing across Beijing, Tokyo, London, Hong Kong, and Shenzhen. Holds a BA in Economics from Peking University and an MS in Finance from London Business School.
Partner with over 15 years of experience in healthcare and life sciences spanning neuroscience research, marketing research, and investment. Holds a BS in Biology from Peking University, an MS in Neuroscience from Boston University, and an MBA from Washington University in St. Louis.
Partner with over 20 years of experience in the pharmaceutical industry, including roles at Brightech International, Theravance, Anacor Pharmaceuticals, and Kosan Biosciences. Holds a BS in Chemistry from Peking University and an MS in Biochemistry and Molecular Biology from the University of Iowa.
Partner with over 30 years of experience as a serial entrepreneur and senior manager/board member at public and private companies in Hong Kong and mainland China.
Partner with over 30 years of experience as a serial entrepreneur across hi-tech, retail chains, bulk commodities, new energy, animation studios, creative parks, and real estate, as well as a venture capitalist. Holds a BS in Materials and an MS in Systems Engineering from Shanghai Jiao Tong University.
What they invest in
from 8 of 19 portfolio companiesHardware ×5Medical Devices ×5Healthtech ×4Deep Tech ×2Media & Entertainment ×2Biotech ×1Digital Health ×1Fintech ×1
HQs:China×4United Kingdom×1Israel×1United States×1
Investments · 19 tracked
founders shown can be your intro pathGuangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.
Caretaker Medical develops wireless medical devices for non-invasive continuous hemodynamic monitoring using patented Pulse Decomposition Analysis technology.
Digital HealthHardwareHealthtechMedical DevicesCharlottesville, US
Martin Baruch(Executive Officer, Director)inJeff Pompeo(Executive Officer, Director, Promoter)inTodd Hochrein(Executive Officer, Director)in
BoardMark Rausch(Director)inPaul Jansen(Director)Rolf Hueppi(Director)
Co-investorsEarly Light VenturesIrishAngelsRiptide Ventures
Edadoc (Yibo) is a Chinese electronics engineering services company focused on PCB design, high-speed circuit layout, and related hardware development support.
Deep TechHardwareRoboticsShenzhen, CN
EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.
BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsF-Prime Capital
Chengdu-based developer of AAV-based gene therapies for conditions such as AMD and XLRS.
Gordian Surgical develops innovative wound closure solutions for laparoscopic and robotic surgeries, designed to enhance surgical efficiency and patient outcomes.
HardwareMedical Devices
Co-investorsTrendlines GroupVirtus Inspire Ventures
Human Xtensions develops HandX, a handheld surgical device with detachable single-use instruments intended to bridge the gap between laparoscopic and robotic surgery.
HardwareHealthtechMedical Devices
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Co-investorsDelta PartnersSHS CapitalBek VenturesQuest for GrowthYonghua Capital
PEDaily is a Chinese investment news platform that publishes weekly venture capital and startup funding announcements, covering companies across sectors including artificial intelligence, semiconductors, robotics, and biotechnology.
FintechMedia & Entertainment
Co-investorsFortune Venture Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Binghui BiopharmaBinhui BiopharmaCarbon EnergyCucopEDADOC TechnologyEureka BiotechKeystone HeartSupoinSVisionSVision Imaging
Frequently asked questions
- How many investments has Ming capital made?
- Ming capital has 19 tracked investments.
- What stage does Ming capital invest at?
- Ming capital invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Ming capital focus on?
- Ming capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics.
- Where is Ming capital located?
- Ming capital is headquartered in Shenzhen, CN.
- Who does Ming capital co-invest with?
- Ming capital most often shares deals with China Growth Capital, Early Light Ventures, F-Prime Capital, among 14 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.